Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Top Cited Papers
Open Access
- 17 May 2016
- journal article
- research article
- Published by Elsevier in The Lancet Psychiatry
- Vol. 3 (7) , 619-627
- https://doi.org/10.1016/s2215-0366(16)30065-7
Abstract
No abstract availableKeywords
Funding Information
- MRC clinical development (MR/J00460X/1)
This publication has 28 references indexed in Scilit:
- Psychedelics and Mental Health: A Population StudyPLOS ONE, 2013
- Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal StudyPLOS ONE, 2012
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled StudyNeuropsychopharmacology, 2012
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinProceedings of the National Academy of Sciences, 2012
- Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteersDrug and Alcohol Dependence, 2011
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogensPublished by Elsevier ,2011
- Identifying Difficult-to-Treat DepressionThe Journal of Clinical Psychiatry, 2009
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology, 2008
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008
- Role of the Serotonin 5-HT2AReceptor in LearningLearning & Memory, 2003